Rise and shine, everyone, another busy day is on the way. And it is getting off to a pleasant start here on the Pharmalot campus, where clear blue skies and comfy breezes are greeting us.
Who could ask for anything more? Actually, we could — it is time to reheat the kettle for another cuppa stimulation.
Our choice today is raspberry hibiscus. And here is a helpful tip: A teaspoon of honey enhances the flavors splendidly.
Of course, you are invited to join us. For the full experience, we are hawking replicas —  take a look .
Meanwhile, here are a few tidbits to help you along. As always, do keep in touch.
We appreciate feedback, criticism, and tips. … GSK agreed to buy Nuvalent, a cancer drug developer, in a deal worth $10.6 billion, as the company continues its expansion in oncology , STAT writes.
STAT News published a clinical update in Research Highlights on 09 Jun 2026.
The item focuses on STAT+: Pharmalittle: We’re reading about a $10.6 billion GSK deal, an AstraZeneca obesity pill, and more.
Review the original article for the full source wording and details.